These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28003721)

  • 1. Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.
    Patel A; Seetharam A
    J Clin Exp Hepatol; 2016 Dec; 6(4):311-318. PubMed ID: 28003721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Aspects in the Management of Cholestatic Liver Diseases.
    Chazouillères O
    Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales.
    Colapietro F; Gershwin ME; Lleo A
    J Transl Autoimmun; 2023; 6():100188. PubMed ID: 36684809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis.
    Schramm C; Wedemeyer H; Mason A; Hirschfield GM; Levy C; Kowdley KV; Milkiewicz P; Janczewska E; Malova ES; Sanni J; Koo P; Chen J; Choudhury S; Klickstein LB; Badman MK; Jones D
    JHEP Rep; 2022 Nov; 4(11):100544. PubMed ID: 36267872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection.
    Bowlus CL
    Hepat Med; 2016; 8():89-95. PubMed ID: 27621676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obeticholic acid-a new therapy in PBC and NASH.
    Chapman RW; Lynch KD
    Br Med Bull; 2020 May; 133(1):95-104. PubMed ID: 32282030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
    D'Amato D; De Vincentis A; Malinverno F; Viganò M; Alvaro D; Pompili M; Picciotto A; Palitti VP; Russello M; Storato S; Pigozzi MG; Calvaruso V; De Gasperi E; Lleo A; Castellaneta A; Pellicelli A; Cazzagon N; Floreani A; Muratori L; Fagiuoli S; Niro GA; Feletti V; Cozzolongo R; Terreni N; Marzioni M; Pellicano R; Pozzoni P; Baiocchi L; Chessa L; Rosina F; Bertino G; Vinci M; Morgando A; Vanni E; Scifo G; Sacco R; D'Antò M; Bellia V; Boldizzoni R; Casella S; Omazzi B; Poggi G; Cristoferi L; Gerussi A; Ronca V; Venere R; Ponziani F; Cannavò M; Mussetto A; Fontana R; Losito F; Frazzetto E; Distefano M; Colapietro F; Labanca S; Marconi G; Grassi G; Galati G; O'Donnell SE; Mancuso C; Mulinacci G; Palermo A; Claar E; Izzi A; Picardi A; Invernizzi P; Carbone M; Vespasiani-Gentilucci U;
    JHEP Rep; 2021 Apr; 3(2):100248. PubMed ID: 33681748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Current Understanding of Bile Acids in Chronic Liver Disease.
    Farooqui N; Elhence A; Shalimar
    J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.
    Overi D; Carpino G; Cristoferi L; Onori P; Kennedy L; Francis H; Zucchini N; Rigamonti C; Viganò M; Floreani A; D'Amato D; Gerussi A; Venere R; Alpini G; Glaser S; Alvaro D; Invernizzi P; Gaudio E; Cardinale V; Carbone M
    JHEP Rep; 2022 Nov; 4(11):100556. PubMed ID: 36267871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
    Abbas N; Culver EL; Thorburn D; Halliday N; Crothers H; Dyson JK; Phaw A; Aspinall R; Khakoo SI; Kallis Y; Smith B; Patanwala I; McCune A; Chimakurthi CR; Hegade V; Orrell M; Jones R; Mells G; Thain C; Thain RM; Jones D; Hirschfield G; Trivedi PJ
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1561-1570.e13. PubMed ID: 35961518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists.
    Abenavoli L; Procopio AC; Fagoonee S; Pellicano R; Carbone M; Luzza F; Invernizzi P
    Diseases; 2020 Jun; 8(2):. PubMed ID: 32532037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
    Manley S; Ding W
    Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obeticholic acid in primary biliary cholangitis: where we stand.
    Manne V; Kowdley KV
    Curr Opin Gastroenterol; 2019 May; 35(3):191-196. PubMed ID: 30844895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis.
    Burman BE; Jhaveri MA; Kowdley KV
    Clin Liver Dis; 2017 Nov; 21(4):709-723. PubMed ID: 28987258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.
    Bahar R; Wong KA; Liu CH; Bowlus CL
    Gastroenterol Hepatol (N Y); 2018 Mar; 14(3):154-163. PubMed ID: 29928160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and emerging therapies for cholestatic liver diseases.
    Goldstein J; Levy C
    Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of farnesoid X receptor agonists.
    Ali AH; Carey EJ; Lindor KD
    Ann Transl Med; 2015 Jan; 3(1):5. PubMed ID: 25705637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis.
    Harms MH; Hirschfield GM; Floreani A; Mayo MJ; Parés A; Liberman A; Malecha ES; Pencek R; MacConell L; Hansen BE
    JHEP Rep; 2021 Feb; 3(1):100191. PubMed ID: 33319187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel.
    Alvaro D; Carpino G; Craxi A; Floreani A; Moschetta A; Invernizzi P
    Liver Int; 2020 Nov; 40(11):2590-2601. PubMed ID: 32757367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.